NCG
LLY icon

Newport Capital Group’s Eli Lilly LLY Stock Holding History

Newport Capital Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-266
Closed -$245K – 66
2026
Q1 		$245K Buy
266
+24
+10% +$24.3K 0.15% 65
2025
Q4 		$260K Buy
+242
New +$231K 0.16% 58

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
GIM
Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Newport Capital Group's LLY Position: Q2 2026 in Review

Newport Capital Group sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 266 shares — an estimated $245K sold.

Newport Capital Group first reported a position in LLY in Q4 2025 and held it in 2 quarters. The position peaked at $260K in Q4 2025. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Newport Capital Group reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
  • Newport Capital Group sold 266 Eli Lilly shares in Q2 2026, an estimated $245K.
  • Newport Capital Group first reported a position in Eli Lilly in Q4 2025 and held it in 2 quarters.
  • Newport Capital Group's Eli Lilly position peaked at $260K in Q4 2025.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Newport Capital Group's 13F filing for Q2 2026, filed 21 Jul 2026.